France / Français
Master Doctor Search: Rheumatoid arthritis
Biosimilar and Interchangeable Biologics: More Treatment Choices
The FDA has approved biosimilar medications to treat conditions such as cancer, diabetes, Crohn's disease, colitis, rheumatoid arthritis, psoriasis, and more.
1 month ago - NCCIH
Even low-dose glucocorticoids greatly increase vertebral fracture risk in RA
Patients with rheumatoid arthritis who receive even low daily doses of glucocorticoids are at a 59% increased risk for clinical vertebral fracture, according to data published...
1 month ago - Healio - 5 articles
Could Fermented Foods Help Your Arthritis?
Recent research 1 has shown that fermented foods not only can improve gut microbiome diversity, but lower the inflammatory response in your body that affects conditions like...
1 month ago - Mercola
Rheumatoid arthritis-ILD associated with excess mortality
Rheumatoid arthritis-related interstitial lung disease was associated with significantly higher rates of excess mortality compared with the general population, according to new...
1 month ago - Healio
COVID-19 demand leads to Australian shortages of rheumatoid arthritis drug
The medicines regulator and pharma giant Roche are monitoring the availability of arthritis treatment Actemra, which has had supply constrained by overseas use for COVID-19.
1 month ago - Sydney Morning Herald
Daily glucocorticoids exceeding 5 mg 'threshold' linked to higher cardiovascular risk in RA
Daily glucocorticoid doses of 5 mg or more during the preceding 6 or 12 months is associated with an increased risk for cardiovascular events in steroid-naïve patients with...
1 month ago - Healio
AbbVie, Lilly Face Fresh Delays in FDA Approval for Expanded Use of Arthritis Drugs
AbbVie and Lilly are facing fresh delays in the approval of their respective rheumatoid arthritis drugs for treating the chronic skin disease eczema as the US health regulator...
1 month ago - Medscape - 4 articles
Fracture Risk in RA: 'Reassuring' Results for Biologics, Synthetic Agents
There were no differences in risk of nonvertebral fragility fractures among patients with rheumatoid arthritis according to their use of individual biologic and targeted...
2 monthes ago - MedPageToday
Anti-rheumatic drug combinations could reduce the risk of heart attack and strokes
New research evaluating the drugs commonly used by rheumatoid arthritis patients suggests two combinations could reduce the risk of heart attack and strokes.
2 monthes ago - News Medical
Five 'distinct disease activity trajectories' identified in RA treated with tofacitinib
Researchers have identified five distinct phenotypic subgroups based on disease trajectory among methotrexate-naïve patients with rheumatoid arthritis receiving tofacitinib...
2 monthes ago - Healio
Free Registration
The headlines of Master Doctor
FDA approves selexipag for IV use in adults with PAH
The FDA has approved selexipag for IV use in adults with WHO functional class II to III pulmonary arterial hypertension who are temporarily unable to take oral...
Obesity does not increase risk for serious infection in biologic-treated IBD
Obesity was not associated with an increased risk for serious infection among patients with inflammatory bowel disease treated with biologics, according to research published...
Many women with gestational diabetes do not receive type 2 diabetes...
Women in the United Kingdom who had gestational diabetes were not often screened for type 2 diabetes in accordance with national guidelines, a recent analysis showed. According...
Influenza vaccine may provide additional protection from COVID-19
Influenza vaccination may reduce the risk for stroke, sepsis and deep vein thrombosis in patients with COVID-19, data presented at the ECCMID virtual meeting...
Vanilla Bean Mini Sheet Cake from Trader Joe's PFAS “Forever Chemicals” Lab...
Does the Chantilly Cream Vanilla Bean Mini Sheet Cake from Trader Joe's have any indication of PFAS contamination in the food packaging? This is what you've been asking us to...
FDA approves Shingrix for prevention of shingles in immunocompromised adults
The FDA this week approved Shingrix for the prevention of shingles in immunocompromised adults, GlaxoSmithKline announced. Shingrix , is a nonlive, recombinant sub-unit...
FDA approves Twyneo cream for acne vulgaris
Twyneo cream, a fixed-dose combination of tretinoin and benzoyl peroxide, has been approved by the FDA for the treatment of acne vulgaris, Sol-Gel Technologies announced in a...
FDA OKs emergency use of baricitinib alone for COVID-19
The FDA has authorized emergency use of baricitinib alone for the treatment of patients aged 2 years and older who are hospitalized with COVID-19. The authorization applies to...
VIDEO: Bausch + Lomb pipeline includes NOV03 for dry eye disease
LAS VEGAS - In this Healio Video Perspective from the ASCRS meeting, Yolande Barnard, vice president and general manager, U.S. Pharmaceuticals, Bausch + Lomb, offers updates on...
Low vision patients not routinely tested for dry eye disease despite high risk
Results from a retrospective chart review on dry eye disease and low vision showed low vision patients are at risk for dry eye disease, but low numbers of dry eye disease tests...